New Review in Cells
Published:
We are pleased to announce the publication of our latest review article Cytokine Regulation of the Bone Pre- and Metastatic Niches: Implications for Breast Cancer Dormancy in Cells. The review examines how cytokine signalling within the bone microenvironment regulates the homing, dormancy and subsequent re-awakening of disseminated breast cancer cells.
Bone metastasis remains a major clinical challenge in breast cancer, with disseminated tumour cells capable of entering a prolonged dormant state before re-emerging years after treatment of the primary tumour. The review explores how interactions between tumour cells and the bone microenvironment establish and regulate this dormant state, with a particular focus on the complex cytokine and immune signalling networks that shape the pre-metastatic and metastatic niches.
We highlight the roles of cytokines and chemokines including LIF, TGF-β, FGF, CXCL9, CXCL10 and CXCL12 in regulating tumour cell homing and dormancy, alongside signalling pathways that can promote dormancy escape and metastatic outgrowth. Importantly, many of these factors have context-dependent roles across different stages of metastatic progression, illustrating the complexity of the interactions between tumour cells, immune populations, osteoblasts, osteoclasts and other components of the bone microenvironment.
The review also considers the therapeutic implications of understanding these signalling networks, including approaches aimed at maintaining disseminated tumour cells in a dormant state or selectively eliminating dormant cells before they can re-awaken. Developing strategies that target these persistent tumour cell populations represents an important opportunity to prevent late metastatic relapse and improve long-term outcomes for patients with breast cancer.
This work forms part of our ongoing collaboration with the Sheffield Laboratory for Dormancy and Metastasis and contributes to our wider research programme investigating the mechanisms that enable cancer cells to survive, persist and ultimately drive metastatic recurrence.
